Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 25;13(4):98551.
doi: 10.5501/wjv.v13.i4.98551.

Acceptance of COVID-19 vaccine and its related determinants in Nigeria: An online survey

Eyiuche D Ezigbo  1 , Seyi S Enitan  2 , Esther N Adejumo  3 , Abiodun E Durosinmi  4 , Richard Y Akele  5 , Michael O Dada  3 , Grace E Itodo  6 , Abah M Idoko  7 , Okeoghene M Edafetanure-Ibeh  8 , Edwin N Okafor  9 , Adedeji A Abdulsalam  10 , Oyekan I Oyedoyin  11 , Polit U Yelpoji  12 , Ogunwola O Opeyemi  13 , Ogbuji S Nmesomachi  14 , Adesola O Oyekale  15 , Chisom B Onyeji  3
Affiliations

Acceptance of COVID-19 vaccine and its related determinants in Nigeria: An online survey

Eyiuche D Ezigbo et al. World J Virol. .

Abstract

Background: Vaccine hesitancy is a major challenge in the fight against the coronavirus disease 2019 (COVID-19) pandemic. Identifying the sociodemographic factors associated with vaccine acceptance among Nigerians is crucial for improving vaccine uptake.

Aim: To assess the acceptance rate of COVID-19 vaccine and its related determinants among Nigerians.

Methods: An online cross-sectional survey (observational study) was conducted between February 2021 and May 2021, using a questionnaire hosted on SurveyMonkey. The invitation to take part in the poll was sent out to participants through social networking platforms. A logistic regression was used to determine which sociodemographic factors were associated with vaccine acceptance constructs.

Results: A total of 1800 persons responded to the survey, a larger proportion of whom were males (53.9%) and within the age group of 21-30 years (29.4%) and earned an average income of less than $500 per month (43.3%). Only 0.56% of participants had a high perceived risk of COVID-19 infection, while only 1.11% had a perceived risk of dying from COVID-19. The perception rate of the COVID-19 vaccine among participants was 51.1%, while the acceptance rate was 63.9%. There was no significant association between the COVID-19 vaccine acceptance rate and related determinants assessed, particularly age (χ² = 3.049, P = 0.550), sex (χ² = 0.102, P = 0.749), average income (χ² = 3.802, P = 0.875), and religion (χ² = 2.819, P = 0.420). Participants with chronic conditions demonstrated a higher acceptance rate compared to the general population.

Conclusion: Despite the positive perception observed and substantial vaccine acceptance rate among the study participants, more public health interventions are still needed to enhance vaccine acceptability in Nigeria.

Keywords: Acceptance; COVID-19; Determinants; Hesitancy; Nigerians; Online survey; Vaccine.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Figures

Figure 1
Figure 1
Perception on vaccination and social distancing measures among the study participants.
Figure 2
Figure 2
Perceived risk of getting infected with the coronavirus disease 2019 in the next month.
Figure 3
Figure 3
Perceived risk of dying from the coronavirus disease 2019 if infected.
Figure 4
Figure 4
Overall coronavirus disease 2019 vaccine acceptance rate among the study participants.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Okai GA, Abekah-Nkrumah G. The level and determinants of COVID-19 vaccine acceptance in Ghana. PLoS One. 2022;17:e0270768. - PMC - PubMed
    1. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Singh KP, Chaicumpa W, Bonilla-Aldana DK, Rodriguez-Morales AJ. Coronavirus Disease 2019-COVID-19. Clin Microbiol Rev. 2020;33:e00028– e00020. - PMC - PubMed
    1. Ehrenberg JP, Utzinger J, Fontes G, da Rocha EMM, Ehrenberg N, Zhou XN, Steinmann P. Efforts to mitigate the economic impact of the COVID-19 pandemic: potential entry points for neglected tropical diseases. Infect Dis Poverty. 2021;10:2. - PMC - PubMed
    1. Burki T. Global COVID-19 vaccine inequity. Lancet Infect Dis. 2021;21:922–923. - PMC - PubMed
    1. Ahmed MAM, Colebunders R, Gele AA, Farah AA, Osman S, Guled IA, Abdullahi AAM, Hussein AM, Ali AM, Siewe Fodjo JN. COVID-19 Vaccine Acceptability and Adherence to Preventive Measures in Somalia: Results of an Online Survey. Vaccines (Basel) 2021;9:543. - PMC - PubMed

LinkOut - more resources